• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎感染与慢性肾脏病各期的关系在年龄和性别上的差异。

Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease.

机构信息

Department of Occupation Medicine, Chang-Gung Memorial Hospital at Keelung, Keelung, Taiwan.

出版信息

J Viral Hepat. 2014 Oct;21(10):706-15. doi: 10.1111/jvh.12199. Epub 2013 Dec 5.

DOI:10.1111/jvh.12199
PMID:24304473
Abstract

Chronic kidney disease (CKD) is a worldwide health issue with heavy economic burden. Chronic hepatitis C virus (HCV) infection is a common cause of CKD, which can significantly impact the progression and mortality among patients with CKD. The prevalence of both illnesses is high in Taiwan. A multicentre and population-based cross-sectional study including 24 642 subjects was conducted to explore the association of HCV infection with the prevalence and severity of CKD. The measurements of metabolic parameters, eGFR and CKD stages were compared between subjects with HCV seropositivity and seronegativity. The analyses of association between HCV infection with CKD stages and evaluation of potential risk factors of CKD were performed by gender and age (≤ and >45 years). HCV-seropositive subjects accounted for 6.9% and had a significantly older age. The prevalence of CKD increased in those with HCV seropositivity (16.5%). Significantly higher prevalence of CKD stages ≥3 in HCV-seropositive subjects was noticed (7.8%). Age (>45 year), male gender, alcohol drinking, hypertension, creatinine and HCV infection were the significant factors associated with the presence of CKD. HCV seropositivity was an independent risk factor of developing CKD and associated with an increased risk of having CKD of all stages. The higher prevalence of earlier stage of CKD warrants longitudinal studies with frequent testing on renal function and sufficient duration to determine the changes of eGFR over time. Implementation of effective treatment intervention is also required for these subjects to prevent the progression of CKD to late stages.

摘要

慢性肾脏病(CKD)是一个全球性的健康问题,带来了沉重的经济负担。慢性丙型肝炎病毒(HCV)感染是 CKD 的一个常见病因,它会显著影响 CKD 患者的进展和死亡率。这两种疾病在台湾的发病率都很高。本项多中心、基于人群的横断面研究共纳入 24642 名受试者,旨在探讨 HCV 感染与 CKD 患病率和严重程度的关系。比较了 HCV 血清阳性和阴性受试者的代谢参数、eGFR 和 CKD 分期的测量值。通过性别和年龄(≤45 岁和>45 岁)分析了 HCV 感染与 CKD 分期的关系,并评估了 CKD 的潜在危险因素。HCV 血清阳性受试者占 6.9%,年龄明显较大。HCV 血清阳性受试者的 CKD 患病率增加(16.5%)。HCV 血清阳性受试者的 CKD 分期≥3 的患病率明显较高(7.8%)。年龄(>45 岁)、男性、饮酒、高血压、肌酐和 HCV 感染是与 CKD 发生相关的显著因素。HCV 血清阳性是 CKD 发生的独立危险因素,与所有 CKD 分期的发生风险增加相关。CKD 早期阶段的高患病率需要进行纵向研究,频繁进行肾功能检测,并进行足够长的随访以确定 eGFR 随时间的变化。还需要对这些患者实施有效的治疗干预,以防止 CKD 进展到晚期。

相似文献

1
Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease.丙型肝炎感染与慢性肾脏病各期的关系在年龄和性别上的差异。
J Viral Hepat. 2014 Oct;21(10):706-15. doi: 10.1111/jvh.12199. Epub 2013 Dec 5.
2
Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.台湾流行地区丙型和乙型肝炎病毒感染与慢性肾脏病的相关性:一项横断面研究。
Am J Kidney Dis. 2010 Jul;56(1):23-31. doi: 10.1053/j.ajkd.2010.01.015. Epub 2010 Apr 18.
3
High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.高丙型肝炎病毒载量和基因型 2 是慢性肾脏病的强烈预测因子。
Kidney Int. 2017 Sep;92(3):703-709. doi: 10.1016/j.kint.2017.03.021. Epub 2017 May 20.
4
Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.在社区人群中使用慢性肾脏病流行病学协作组(CKD-EPI)公式进行估算肾小球滤过率常规报告的影响:一项横断面队列研究。
Nephrology (Carlton). 2014 Sep;19(9):581-6. doi: 10.1111/nep.12283.
5
Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.晚期慢性肾脏病老年人群的死亡风险增加:台湾的一项队列研究
Nephrol Dial Transplant. 2008 Oct;23(10):3192-8. doi: 10.1093/ndt/gfn222. Epub 2008 May 1.
6
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.丙型肝炎病毒血症会增加 HIV 感染患者发生慢性肾脏病的几率。
AIDS. 2012 Sep 24;26(15):1917-26. doi: 10.1097/QAD.0b013e3283574e71.
7
Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate.丙型肝炎病毒感染与蛋白尿和肾小球滤过率的关联
Clin Transl Sci. 2015 Oct;8(5):421-4. doi: 10.1111/cts.12321. Epub 2015 Aug 14.
8
The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional Analysis.丙型肝炎病毒、代谢紊乱和不健康行为对慢性肾脏病的影响:二次横断面分析。
Int J Environ Res Public Health. 2022 Mar 17;19(6):3558. doi: 10.3390/ijerph19063558.
9
A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者慢性肾脏病风险的荟萃分析评估
J Viral Hepat. 2015 Nov;22(11):897-905. doi: 10.1111/jvh.12413. Epub 2015 Apr 22.
10
Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.慢性丙型肝炎与慢性肾脏病:进展、局限与未知领域
J Viral Hepat. 2017 Jun;24(6):442-453. doi: 10.1111/jvh.12681. Epub 2017 Feb 22.

引用本文的文献

1
Renal Function in Chronic Hepatitis C Patients in Mongolia.蒙古国慢性丙型肝炎患者的肾功能
Diagnostics (Basel). 2025 Jun 10;15(12):1471. doi: 10.3390/diagnostics15121471.
2
The Role of Direct-Acting Antivirals in Enhancing Quality of Life Among Individuals with Chronic Hepatitis C.直接抗病毒药物在提高慢性丙型肝炎患者生活质量中的作用。
Healthcare (Basel). 2025 Apr 11;13(8):878. doi: 10.3390/healthcare13080878.
3
Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients.
慢性丙型肝炎患者接受直接抗病毒治疗后估计肾小球滤过率的变化
Diseases. 2025 Jan 21;13(2):26. doi: 10.3390/diseases13020026.
4
Public healthcare system utilization for chronic hepatitis C infection in Vietnam.越南公共医疗体系对慢性丙型肝炎感染的利用情况。
BMC Infect Dis. 2023 Nov 16;23(1):802. doi: 10.1186/s12879-023-08726-7.
5
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.泛基因型直接作用抗病毒药物治疗慢性肾脏病 4 或 5 期合并丙型肝炎病毒感染患者。
Hepatol Int. 2022 Oct;16(5):1001-1019. doi: 10.1007/s12072-022-10390-z. Epub 2022 Jul 25.
6
The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional Analysis.丙型肝炎病毒、代谢紊乱和不健康行为对慢性肾脏病的影响:二次横断面分析。
Int J Environ Res Public Health. 2022 Mar 17;19(6):3558. doi: 10.3390/ijerph19063558.
7
Hepatitis C infection and chronic kidney disease among Hispanics/Latinos.丙型肝炎感染与西班牙裔/拉丁裔人群的慢性肾脏病。
Medicine (Baltimore). 2021 Dec 10;100(49):e28089. doi: 10.1097/MD.0000000000028089.
8
The development and pilot testing of an ACP simulation-based communication-training program: Feasibility and acceptability.ACP 模拟为基础的沟通培训计划的开发和试点测试:可行性和可接受性。
PLoS One. 2021 Aug 24;16(8):e0254982. doi: 10.1371/journal.pone.0254982. eCollection 2021.
9
Hepatitis C virus antibodies in outpatients with chronic kidney disease.慢性肾脏病门诊患者的丙型肝炎病毒抗体
Clin Exp Hepatol. 2018 Dec;4(4):267-270. doi: 10.5114/ceh.2018.80129. Epub 2018 Dec 3.
10
The association of hepatitis C infection with the onset of CKD and progression into ESRD.丙型肝炎感染与慢性肾脏病的发生及进展为终末期肾病的关联。
Semin Dial. 2019 Mar;32(2):108-118. doi: 10.1111/sdi.12759. Epub 2018 Nov 29.